# PharmaResearch Co.,Ltd: Observational study in Skin Aging, Horizontal Neck Lines (30 participants)

**Score:** 75/100

| Field | Value |
|---|---|
| Sponsor | PharmaResearch Co.,Ltd |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | Clinical Evaluation of Dual-Plane Technique PN-Based Treatment for Horizontal Neck Lines Using DNA Fragment Opmizing Technology Polynucleotide (DOT PN) |
| NCT ID | NCT07912879 |
| Phase | Observational |
| Status | not yet recruiting |
| Conditions | Skin Aging; Horizontal Neck Lines |
| Intervention types | device |
| Target enrollment | 30 |
| Site countries | Malaysia, Singapore, Thailand |
| Posted | 2026-11-03 |
| Planned start | 2026-11-15 |
| Event | Newly registered study |
| Event date | 2026-11-03 |

## Why this score
- Posted in the last two weeks.
- Industry sponsor (buys outsourced services).
- Not yet recruiting: vendors still being chosen.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07912879). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.